Skip to main content
Clinical Trials/ACTRN12612001100886
ACTRN12612001100886
Recruiting
未知

se of myocardial tissue characterization by cardiac magnetic resonance imaging to predict left ventricular dysfunction in patients undergoing anthracycline chemotherapy.

Dr James Hare0 sites50 target enrollmentOctober 16, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
Anthracycline chemotherapy induced cardiac toxicity
Sponsor
Dr James Hare
Enrollment
50
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 16, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Dr James Hare

Eligibility Criteria

Inclusion Criteria

  • Patient referred for anthracycline chemotherapy (i.e. for lymphoma)
  • Healthy controls

Exclusion Criteria

  • 1\. Acute renal failure or chronic renal failure manifest by GFR\<60 ml/kg/1\.73m2\.
  • 2\. Contraindication to MRI scanning.
  • 3\. Known hypersensitivity to gadolinium.
  • 4\. Atrial fibrillation at baseline.
  • 5\. Pregnancy.

Outcomes

Primary Outcomes

Not specified

Similar Trials